chemagic 360
The chemagic™ chemagic 360 instrument is a flexible compact solution for automated nucleic extraction from diverse sample materials.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
gives you time for a tea
DNA extraction
Requires a fair bit of prep depending on the sample type.... but I'm sure that is the same for any automated extraction. Engineers come when needed, for the odd breakdown and service. Takes about 70 mins but reduces hands on time, letting you do something whilst samples are being extracted. Not as fast as some methods but still a helpful tool in the lab. Easy to use. Not exactly cheap to run though, but good for large runs.
Review Date: 12 May 2023 | Revvity
Robust, high-throughput, easy to use system
Nucleic acid extraction
This semi-automated extraction system is easy to use and produces high quality nucleic acids at an adequate yield. It is durable and most problems we have observed are minor and easily remedied. Service is satisfactory.
Review Date: 31 Oct 2022 | Revvity
Great results.
DNA Extraction
High quality DNA is achieved and the concentration is consistent!
Review Date: 1 Nov 2018 | Revvity
Still waiting for a better result.
DNA genomic analyses, including classic and next generation sequencing
It is very user-friendly. But it does not use primary tubes, i.e. the user has to pipette the protein kinase in each well and then add the blood manually, impairing a high quality tracking of samples. We are beginning to make our first extractions and still too many beads remain in the final DNA eluate. I mean they are visible giving rise to a pink-brownish solution. We have been told to centrifuge the DNA and change to a new DNA vial to take them out, and it works, but this will further increase the traceability of samples.
Review Date: 20 Apr 2018 | Revvity
Gives the best quality DNA
Extraction
Yields quality DNA and allows the tech to have less manual interaction.
Review Date: 15 Feb 2018 | Revvity
The chemagic 360 instrument is based on the well-established magnetic bead based chemagic Technology and the system offers a reliable solution for different sample materials and throughput needs. Configurable with three kinds of chemagic Rod Heads, the system can process sample volumes from 50 µl - 18 ml and the isolated DNA/RNA is suitable for a wide range of downstream applications such as NGS, MPLA, genotypic, and PCR.
Driving precision oncology with chemagic technology
Despite its great value as a biomarker, extracting and purifying circulating free DNA (cfDNA) has traditionally posed challenges due to its low concentration and high level of fragmentation within the bloodstream. Revvity’s chemagic™ technology promises to offer a robust solution to address these challenges. Leveraging M-PVA magnetic bead technology to extract cfDNA from large plasma volumes, the DNA extraction and purification platform is designed to maximize yield and purity. When combined with advanced quantification technology such as Droplet Digital™ PCR (ddPCR), the workflow provides precision and repeatability in early cancer biomarker research.
In this case study, Revvity explores how chemagic DNA extraction and purification technology is helping to optimize results.
Whole genome sequencing is driving improved health outcomes for newborns
Millions of people (many of them infants and young children) suffer from misdiagnosed or undiagnosed diseases due to insufficient genetic testing. Whole genome sequencing (WGS) has the potential to streamline genetic assessments and help provide early intervention.
In this case study, Revvity assesses the clinical utility of genome sequencing versus a gene panel for a curated set of medically actionable pediatric-onset conditions in the largest-to-date cohort of apparently healthy newborns and children tested at a single clinical laboratory.
Revvity broadens relationship with Genomics England to advance genomics in the UK
Collaboration to advance newborn genetic screening, leveraging cutting-edge genomics research and laboratory expertise to detect rare conditions early
Key considerations in automated nucleic acid extraction for pathogen and genetic screening workflows
Join experts Dr. Catherine Goh and Dr. Uwe Jaentges to learn how to avoid the 7 deadly sins of DNA/RNA extractions
Welsh lighthouse laboratory extends contract with PerkinElmer for its COVID-19 solutions
Company’s RT-PCR kits and workflow solutions will continue to safeguard capacity for NHS Test and Trace laboratory
PerkinElmer launches Solus One E. coli O157 Pathogen Detection Assay for beef & beef trim testing
This highly sensitive, cost effective assay is designed for customers who receive a high volume of food samples daily
PerkinElmer to acquire cell engineering company Horizon Discovery
Addition of CRISPR and RNAi offerings to complement PerkinElmer's life sciences and applied genomics solutions, with future opportunities to improve cell based discovery for precision medicine
Important considerations for choosing a SARS-CoV-2 assay: Your questions answered
Watch this on-demand webinar to discover the critical factors when choosing an assay for coronavirus testing
PerkinElmer launches COVID-19 environmental surface testing kits for food processors
The kits aim to detect traces of SARS-CoV-2 virus on surfaces such as plastics, ceramics and stainless steel
PerkinElmer collaborates with Sonora Quest Laboratories to expand COVID-19 testing in Arizona
The strategic partnership aims to catapult COVID-19 diagnostic testing capacity well ahead of the significant demand
How PerkinElmer is helping to combat COVID-19
It's comprehensive SARS-COV-2 offerings span RT-PCR, high throughput RNA extraction, automation, ELISA and lateral flow based serology testing.
PerkinElmer Launches New Solutions to Improve Speed and Effectiveness of Life Sciences Research Processes
New lab automation and screening technologies introduced at 2016 SLAS Conference
